| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/29/2009 | WO2009012785A2 Complexes of an emulgator and a fatty acid |
| 01/29/2009 | WO2009012784A2 Methods for preparing cytotoxic complexes of emulsifier and fatty acid |
| 01/29/2009 | WO2009012679A1 2,2,3a,4-TETRAHYDROTHIOCHROMENE[4,3-C]PYRAZOLE COMPOUNDS, PREPARATION METHOD AND USAGE THEREOF |
| 01/29/2009 | WO2009012647A1 Preparation methods of quinazoline derivatives and their pharmaceutical uses |
| 01/29/2009 | WO2009012601A1 Antigen-adjuvant compositions and methods |
| 01/29/2009 | WO2009012589A1 Vaccines and methods for treatment or prevention of gram negative bacterial infection in a vertebrate subject |
| 01/29/2009 | WO2009012588A1 Immunogenic polypeptides and monoclonal antibodies |
| 01/29/2009 | WO2008146305A3 A pharmaceutical composition having virucidal and spermicidal activity |
| 01/29/2009 | WO2008142094A4 Triazol compounds for treating biofilm formation |
| 01/29/2009 | WO2008115785A3 Multivalent avian influenza vaccines and methods |
| 01/29/2009 | WO2008110918A3 Erythromycin-based macrolides |
| 01/29/2009 | WO2008073142A8 Novel inhibitors of beta-lactamase |
| 01/29/2009 | WO2008070733A3 Macrocyclic hepatitis c serine protease inhibitors and uses therefor |
| 01/29/2009 | WO2008040778A3 Carboxamide 4-[(4-pyridyl)amino] pyrimidines for the treatment of hepatitis c |
| 01/29/2009 | WO2008020180A3 Methods of increasing the sensitivity of cancer cells to dna damage |
| 01/29/2009 | WO2008005565A9 Antiviral phosphinate compounds |
| 01/29/2009 | US20090030257 Anti-microbial photodynamic therapy |
| 01/29/2009 | US20090030088 Therapeutic benefits of gossypol, 6-methoxy gossypol, and 6,6'-dimothxy gossypol |
| 01/29/2009 | US20090030086 Antimicrobial agents |
| 01/29/2009 | US20090030084 Compositions and Methods of Use of Electron Transport System Inhibitors |
| 01/29/2009 | US20090030060 Intravaginal treatment of vaginal infections with metronidazole compositions |
| 01/29/2009 | US20090030054 Cytoplasmic antigens for detection of candida |
| 01/29/2009 | US20090030051 Inhibitors of IMPDH enzyme |
| 01/29/2009 | US20090030049 Medicament for genital herpes |
| 01/29/2009 | US20090030032 Bicyclic Compound, Production and Use Thereof |
| 01/29/2009 | US20090030031 Method of Preferentially Inducing the Biosynthesis of Interferon |
| 01/29/2009 | US20090030030 Arylalkenyl and arylalkynyl substituted imidazoquinolines |
| 01/29/2009 | US20090030029 Novel benzonaphthyridines |
| 01/29/2009 | US20090030019 Purine derivatives having, in particular, anti-proliferative properties, and their biological uses |
| 01/29/2009 | US20090030000 Antiviral agents |
| 01/29/2009 | US20090029998 Thiazole Derivatives and Use Thereof |
| 01/29/2009 | US20090029983 Novel heterocyclic compounds having anti-hbv activity |
| 01/29/2009 | US20090029980 C-7 Isoxazolinyl Quinolone / Naphthyridine Derivatives Useful as Antibacterial Agents |
| 01/29/2009 | US20090029964 Novel carbapenem compound |
| 01/29/2009 | US20090029961 Bio-Film Resistant Surfaces |
| 01/29/2009 | US20090029939 Pre-organized tricyclic integrase inhibitor compounds |
| 01/29/2009 | US20090029908 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS |
| 01/29/2009 | US20090029459 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 01/29/2009 | US20090029444 Novel recombinant anticoagulant proteins |
| 01/29/2009 | US20090028973 Use Of Nocardia Rubra Cell Wall Skeleton In The Preparation Of Anti-HPV Infection Medicaments |
| 01/29/2009 | US20090028947 Using of nanosilver in poultry, livestock and aquatics industry |
| 01/29/2009 | US20090028932 Vaccine formulations for leishmania |
| 01/29/2009 | US20090028931 Liposomal compositions for parenteral delivery of agents |
| 01/29/2009 | US20090028909 Intranasal Vaccine for Use Against Disease Caused by Enterotoxigenic Escherichia Coli |
| 01/29/2009 | US20090028904 Novel cochleate formulations |
| 01/29/2009 | US20090028901 use of such proteins in isolating various types of attenuated viruses for the development of vaccine and pharmaceutical formulations; protocols utilizing interferon antagonists, e.g., NS1, to enhance gene therapy or DNA vaccination based on their ability to increase gene expression |
| 01/29/2009 | US20090028900 West nile viruses with mutations in the 3' terminal stem and loop secondary structure for use as live virus vaccines |
| 01/29/2009 | US20090028894 Papilloma Virus Capsomere Vaccine Formulations and Methods of Use |
| 01/29/2009 | US20090028893 Methods for producing fusion polypeptides or enhancing expression of fusion polypeptides |
| 01/29/2009 | US20090028891 Chlamydia Antigens and Uses Thereof |
| 01/29/2009 | US20090028890 encodes an HIV-1 MA polypeptide myristate binding site; capable of selectively eliciting a substantially th-1 immune response to HIV-1; vaccine |
| 01/29/2009 | US20090028889 Novel Polypeptide Ligands For Toll-Like Receptor 2 (TLR2) |
| 01/29/2009 | US20090028887 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/29/2009 | US20090028882 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/29/2009 | US20090028881 Conjugate of an antibody against CCR5 and an antifusogenic peptide |
| 01/29/2009 | US20090028879 Targetting slow-growing, relatively mutationally-spared cancer; one-step genetic switches; antiproliferative agents; magnetic resonance imaging |
| 01/29/2009 | US20090028877 Antibody Composition Specifically Binding to Ganglioside Gm |
| 01/29/2009 | US20090028874 Synthetic Protein as Tumor-Specific Vaccine |
| 01/29/2009 | US20090028872 Human monoclonal antibodies to cd70 |
| 01/29/2009 | US20090028867 Antagonists Specific For Denatured Collagen And Methods Of Using Same |
| 01/29/2009 | US20090028866 USE OF CCR9, CCL25/TECK, AND NITEGRIN alpha4 IN DIAGNOSIS AND TREATMENT OF MELANOMA METASTASIS IN THE SMALL INTESTINE |
| 01/29/2009 | US20090028864 L-amino acid oxidase with cytotoxic activity from aplysia functata |
| 01/29/2009 | US20090028856 Anti-CD79B Antibodies and Immunoconjugates and Methods of Use |
| 01/29/2009 | US20090028846 Immunoglobulin fractions |
| 01/29/2009 | US20090028844 Galnts as modifiers of the igfr pathway and methods of use |
| 01/29/2009 | US20090028839 Compositions and methods for the prophylaxis and treatment of vaginal infections |
| 01/29/2009 | US20090028835 Human transcriptome corresponding to human oocytes and use of said genes or the corresponding polypeptides to trans-differentiate somatic cells |
| 01/29/2009 | US20090028827 Method for preventing and treating influenza |
| 01/29/2009 | US20090028822 Glycopegylated Interferon Alpha |
| 01/29/2009 | US20090028820 Antiviral Agent |
| 01/29/2009 | US20090028818 Heterocyclic antiviral compounds |
| 01/29/2009 | US20090028801 Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
| 01/29/2009 | US20090028793 Vascular Tumor Markers |
| 01/29/2009 | DE202008011653U1 Wirkstoffkombination, kosmetische oder pharmazeutische Zubereitung und Verpackungseinheit Combination of active ingredients, cosmetic or pharmaceutical preparation and packaging unit |
| 01/29/2009 | DE102007035323A1 New diazen-1-ium-1,2-diolate substituted ketoconazole derivatives are ergosterol biosynthesis inhibitors useful as an active agent against microbial pathogenic germs, e.g. fungus, and an antiinflammatory active agent |
| 01/29/2009 | DE102007035139A1 3-(4-Hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanon und dessen Verwendung als antimikrobieller Wirkstoff 3- (4-hydroxy-3-methoxyphenyl) -1- (4-hydroxyphenyl) -1-propanone and its use as an antimicrobial active substance |
| 01/29/2009 | CA2694466A1 Immunogenic polypeptides and monoclonal antibodies |
| 01/29/2009 | CA2694397A1 Antibody having inhibitory activity on infection with hepatitis c virus (hcv) and use thereof |
| 01/29/2009 | CA2694235A1 Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition |
| 01/29/2009 | CA2694083A1 Antigen-adjuvant compositions and methods |
| 01/29/2009 | CA2693663A1 A conjugate of an antibody against cd4 and antifusogenic peptides |
| 01/29/2009 | CA2693587A1 Metal complexes incorporated within biodegradable nanoparticles and their use |
| 01/29/2009 | CA2693544A1 Antibacterial combination therapy |
| 01/29/2009 | CA2693235A1 Improvements relating to anti-hiv tablet formulations |
| 01/28/2009 | EP2019147A1 Novel k04-0144 substances and process for production thereof |
| 01/28/2009 | EP2019141A2 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 01/28/2009 | EP2019140A2 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 01/28/2009 | EP2019113A1 New Crystalline Salts of 5-Amino-3-(2',3'-di-O-acetyl-beta-D-ribofuranosyl)-3H-thiazolo[4,5-d]pyrimidin-2-one |
| 01/28/2009 | EP2019098A1 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor |
| 01/28/2009 | EP2018872A1 Pharmaceutical product |
| 01/28/2009 | EP2018869A1 Licorice polyphenol preparation |
| 01/28/2009 | EP2018866A1 Pharmaceutical compositions containing voriconazole |
| 01/28/2009 | EP2018862A1 Substituted piperidines as therapeutic compounds |
| 01/28/2009 | EP2018855A1 Pharmaceutical agent |
| 01/28/2009 | EP2018178A2 Administration of agonist-antagonist in opioid-dependent patients |
| 01/28/2009 | EP2018164A2 Use of combination preparations comprising antifungal agents |
| 01/28/2009 | EP2018103A2 Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear |
| 01/28/2009 | EP1648473B1 Single dose fast dissolving azithromycin |
| 01/28/2009 | EP1541672B1 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/28/2009 | EP1495024B1 Dipyridodiazepinones as reverse transcriptase inhibitors |